Silphium Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,649
Closed -$469K 52
2022
Q1
$469K Buy
2,649
+1,300
+96% +$221K 0.56% 37
2021
Q4
$231K Sell
1,349
-1,043
-44% -$171K 0.22% 43
2021
Q3
$386K Buy
+2,392
New +$408K 0.15% 84
2020
Q1
Sell
-2,307
Closed -$337K 26
2019
Q4
$337K Hold
2,307
0.18% 49
2019
Q3
$298K Hold
2,307
0.11% 79
2019
Q2
$321K Hold
2,307
0.09% 73
2019
Q1
$322K Buy
+2,307
New +$309K 0.17% 58
2018
Q4
Sell
-3,406
Closed -$471K 72
2018
Q3
$471K Hold
3,406
0.13% 76
2018
Q2
$413K Hold
3,406
0.13% 63
2018
Q1
$436K Sell
3,406
-2,926
-46% -$395K 0.24% 46
2017
Q4
$885K Buy
+6,332
New +$882K 1.08% 22

Other funds holding JNJ

Silphium Asset Management's JNJ Position: Q2 2022 in Review

Silphium Asset Management sold out of Johnson & Johnson (JNJ) in Q2 2022, closing a stake of 2,649 shares — an estimated $469K sold.

Silphium Asset Management first reported a position in JNJ in Q4 2017 and held it in 11 quarters. The position peaked at $885K in Q4 2017. 3,671 funds tracked by Wall St. Rank hold JNJ as of Q2 2022.

  • Silphium Asset Management reported no remaining Johnson & Johnson position as of Q2 2022 after selling out during the quarter.
  • Silphium Asset Management sold 2,649 Johnson & Johnson shares in Q2 2022, an estimated $469K.
  • Silphium Asset Management first reported a position in Johnson & Johnson in Q4 2017 and held it in 11 quarters.
  • Silphium Asset Management's Johnson & Johnson position peaked at $885K in Q4 2017.
  • 3,671 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2022.

Based on Silphium Asset Management's 13F filing for Q2 2022, filed 30 Jan 2025.